NASDAQ:NCTYThe9 Stock Price, Forecast & News

The9's stock was trading at $0.6387 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NCTY stock has increased by 20.9% and is now trading at $0.7725.
View which stocks have been most impacted by Coronavirus.

The9's stock reverse split on Wednesday, May 9th 2018. The 1-3 reverse split was announced on Tuesday, May 8th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 8th 2018. An investor that had 100 shares of The9 stock prior to the reverse split would have 33 shares after the split.

News articles about NCTY stock have been trending somewhat positive on Monday, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. The9 earned a daily sentiment score of 1.6 on InfoTrie's scale. They also assigned news coverage about the technology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days.
View the latest news about The9.

The9 saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 325,700 shares, an increase of 17.6% from the June 30th total of 276,900 shares. Based on an average trading volume of 1,340,000 shares, the short-interest ratio is currently 0.2 days. Currently, 0.9% of the shares of the stock are sold short.
View The9's Current Options Chain.

Some companies that are related to The9 include China Customer Relations Centers (CCRC), Exela Technologies (XELA), Marchex (MCHX), Heritage Global (HGBL), OmniComm Systems (OMCM), Research Solutions (RSSS), Weyland Tech (WEYL), Dale Jarrett Racing Adventure (TVMD), Steel Connect (STCN), Solbright Group (SBRT), ALJ Regional (ALJJ), SPAR Group (SGRP), DynTek (DYNE), BSQUARE (BSQR) and SilverSun Technologies (SSNT).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other The9 investors own include Amarin (AMRN), Anavex Life Sciences (AVXL), Gevo (GEVO), NovaBay Pharmaceuticals (NBY), Sangamo Therapeutics (SGMO), Verizon Communications (VZ), Advanced Micro Devices (AMD), AVEO Pharmaceuticals (AVEO), Axsome Therapeutics (AXSM) and Conatus Pharmaceuticals (CNAT).

The9 trades on the NASDAQ under the ticker symbol "NCTY."

The9's stock is owned by many different institutional and retail investors. Top institutional shareholders include UBS Group AG (0.53%).

NCTY stock was acquired by a variety of institutional investors in the last quarter, including UBS Group AG.

Shares of NCTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NCTY stock can currently be purchased for approximately $0.77.

The9 has a market capitalization of $23.51 million and generates $50,000.00 in revenue each year. The9 employs 105 workers across the globe.

The official website for The9 is www.the9.com.

The9's mailing address is BUILDING NO.3 690 BIBO ROAD ZHANG JIANG HI-TECH PARK, SHANGHAI F4, 201203. The technology company can be reached via phone at 86-21-5172-9999 or via email at [email protected]